Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812288 · ClinicalTrials.gov registry record
Oxygenation and Muscle Function's Relationship During SLIE in Older Adults
A clinical trial, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 62
- Enrollment target
NCT04812288: Completed study, sponsored by State University of New York at Buffalo.
NCT04812288 is a clinical trial that has completed, run by State University of New York at Buffalo. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04812288 has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This study is to determine the correlations between oxygenation of calf muscles and physical performance including balance, gait speed, and endurance in older adults by utilizing the NIRS device.
Primary Outcome
time to reach the minimum muscular oxygenation level during bilateral heel raise test in seconds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-06-09 |
| Est. Completion | 2019-06-30 |
What the finished NCT04812288 record still lists
NCT04812288 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04812288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04812288 about?
NCT04812288 is a clinical study titled "Oxygenation and Muscle Function's Relationship During SLIE in Older Adults". This study is to determine the correlations between oxygenation of calf muscles and physical performance including balance, gait speed, and endurance in older adults by utilizing the NIRS device.
What is the current status of trial NCT04812288?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2019-06-09. Estimated completion is 2019-06-30.
Who is sponsoring clinical trial NCT04812288?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI